- About
- Advertise
- CureToday.com
- OncLive.com
- OncNursingNews.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2023 MJH Life Sciences™ and Cancer Network. All rights reserved.
Christopher Lieu, MD | Authors
MRD and Decision-Making in Early-Stage Colorectal Cancer
August 20, 2021
This article reviews MRD and decision-making in early-stage colorectal cancer and includes insights from Christopher Lieu, MD, of the University of Colorado School of Medicine in Denver, and Daniel Ahn, DO, of the Mayo Clinic in Phoenix, AZ.
Unmet Needs and Open Questions in Early CRC
August 20, 2021
Dr. Christopher Lieu shares his insights into gaps in care in the adjuvant setting in colorectal cancer.
Personalized MRD Testing in Early CRC
July 23, 2021
An expert in CRC describes key findings from clinical trials related to personalized detection of molecular recurrence in early stage CRC.
Role of ctDNA in Assessing Risk for Recurrence in Early CRC
May 21, 2021
A leader in diagnosis and management of CRC reviews the role of MRD testing in early stage CRC.
Genomic Profiling in Early CRC
March 26, 2021
Christopher Lieu, MD, discusses the standard of care for genomic profiling in early stage CRC.